Mechanisms involved in bone invasion by tumour cells;Mécanismes impliqués dans l'invasion de l'os par les cellules tumorales

Revue du Rhumatisme (Edition Francaise)

Volumn 69, Issue 10-11, 2002, Pages 1002-1009

  Van Der Pluijm, Gabri ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Bone metastasis; Breast neoplasms; Metastatic bone disease; Neoplasm metastasis; Osteoclasts; Pathologic neovascularization.

Indexed keywords

EID: 23744433043     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(02)00430-1     Document Type: Short Survey

References (20)

1. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer.Aug 2002 ; 2 (8) : 584-93.
2. Guise TA, Mundy GR. Cancer and Bone. Endocrine Reviews 1998 ; 19 : 18-54.
3. van der Pluijm G, Lowik C, Papapoulos S. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem. Cancer Treat Rev 2000 ; 26 (1) : 11-27.
4. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889 ; 1 : 571-2.
5. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988 ; 48 : 6876-81.
6. Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 1995 ; 55 : 3551-7.
7. van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Lowik C. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction : elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J Bone Miner Res 2001 ; 16 (6) : 1077-91.
8. van der Pluijm G, Sijmons B, Vloedgraven H, van der Bent C, Drijfhout JW, Verheijen J, Quax P, Karperien M, Papapoulos S, Lowik C. Urokinase-receptor/ integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol 2001 ; 159 (3) : 971-82.
9. Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M, Lowik CW, Gautschi E, Thalmann GN, Cecchini MG. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 2002 ; 160 (3) : 1143-53.
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996 ; 86 : 353-64.
11. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998 ; 91 : 4523-30.
12. Kostenuik PJ, Singh G, Suyama KL, Orr FW. Stimulation of bone resorption results in a selective increase in growth rate of spontaneously metastatic Walker 256 cancer cells in bone. Clin Exp Metastasis 1992 ; 10 : 411-8.
13. Clohisy DR, Ramnaraine ML. Osteoclasts are required for bone tumors to grow and destroy bone. Orthop Res 1998 ; 16 : 660-6.
14. Case Records of the Massachusetts General Hospital (Case 27461). N Engl J Med 1941 ; 22 : 789-91.
15. Guise TA. Parathyroid hormone-related protein and bone metastases. Cancer 1997 ; 15 (; 80) : 1572-80.
16. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ. Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites. Cancer Res 1991 ; 51 : 3059-61.
17. Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM, Martin TJ. Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 1992 ; 7 : 971-9.
18. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR, Guise TA. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest 1999 ; 103 : 197-206.
19. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Reviews 1999 ; 20 : 345-57.
20. Thomas RJ, Guise TA, Yin JJ, Elliot J, Horwood NJ, Martin TJ, Gillespie MT. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 1999 ; 140 : 4451-8.